| 8,080,560 Immune response modifier formulations containing oleic acid and methods
|
0 |
2006
|
| 7,928,116 Method of treating actinic keratosis
|
2 |
2010
|
| 7,906,543 Method of reducing imiquimod impurity formation
|
0 |
2010
|
| 7,919,501 Method of controlling formation of imiquimod impurities
|
0 |
2010
|
| 7,915,277 Method of treating genital or peri-anal warts
|
0 |
2010
|
| 7,915,278 Method of treating basal cell carcinoma
|
0 |
2010
|
| 7,902,242 Method of stabilizing imiquimod
|
12 |
2010
|
| 7,928,117 Method of inducing cytokine biosynthesis
|
2 |
2010
|
| 7,915,279 Method of treating mollescum contagiosum
|
0 |
2010
|
| 7,902,209 Method of preparing a pharmaceutical cream and minimizing imiquimod impurity formation
|
12 |
2010
|
| 7,939,555 Method of preparing a pharmaceutical cream and minimizing imiquimod impurity formation
|
0 |
2010
|
| 7,928,118 Reduction of imiquimod impurities in pharmaceutical creams
|
0 |
2010
|
| 7,923,463 Methods for stabilizing imiquimod for two months, four months, and six months
|
0 |
2010
|
| 7,906,524 Pharmaceutical cream having similar or less levels of imiquimod impurity formation as cream with BHA (comparator)
|
0 |
2010
|
| 7,906,525 Reduction of imiquimod impurities at four months using refined oleic acid
|
0 |
2010
|
| 7,906,526 Method of treating a dermal and/or mucosal associated condition
|
0 |
2010
|
| 7,906,527 Reduction of imiquimod impurities using refined oleic acid
|
0 |
2010
|
| 7,902,210 Reduction of IMIQUIMOD impurities at two months using refined oleic acid
|
12 |
2010
|
| 7,902,211 Method of inducing interferon biosynthesis
|
14 |
2010
|
| 7,902,212 Reduction of imiquimod impurities at six months using refined oleic acid
|
12 |
2010
|
| 7,902,213 Pharmaceutical cream with reduced imiquimod impurities at four months using refined oleic acid
|
12 |
2010
|
| 7,902,214 Method of treating a mucosal and/or dermal associated condition
|
14 |
2010
|
| 7,902,215 Pharmaceutical creams with reduced imiquimod impurities
|
12 |
2010
|
| 7,902,216 Pharmaceutical creams with refined oleic acid
|
13 |
2010
|
| 7,902,243 Methods for improving imiquimod availability at two months, four months and six months between refined and compendial
|
12 |
2010
|
| 7,902,244 Method of preparing a pharmaceutical cream and minimizing imiquimod impurity formation (at least four months storage)
|
12 |
2010
|
| 7,902,245 Methods for reducing imiquimod impurities for two months, four months, and six months
|
12 |
2010
|
| 7,902,246 Methods for controlling formation of imiquimod impurities for two months, four months, and six months
|
12 |
2010
|
